Lithium Controlled-Release and Extended-Release Tablets and Rifadin IV Intravenous
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Rifadin IV Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: Rifadin IV (Intravenous), Rifadin IV
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Rifamate
- Lithium Controlled-Release and Extended-Release Tablets-Rifampin
- Lithium Controlled-Release and Extended-Release Tablets-Rifampin and Isoniazid
- Lithium Controlled-Release and Extended-Release Tablets-Rifampin Capsules
- Lithium Controlled-Release and Extended-Release Tablets-Rifampin Injection
- Lithium Controlled-Release and Extended-Release Tablets-Rifampin Intravenous
- Rifadin IV Intravenous-Lithium ER
- Rifadin IV Intravenous-Lithium Oral Solution
- Rifadin IV Intravenous-Lithium Salts
- Rifadin IV Intravenous-Lithium Syrup and Oral Solution
- Rifadin IV Intravenous-Lithobid
- Rifadin IV Intravenous-Lithostat